Arteris (NASDAQ:AIP) Major Shareholder Bayview Legacy, Llc Sells 41,000 Shares

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 41,000 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $14.21, for a total value of $582,610.00. Following the sale, the insider owned 9,238,071 shares in the company, valued at $131,272,988.91. The trade was a 0.44% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Tuesday, March 10th, Bayview Legacy, Llc sold 9,000 shares of Arteris stock. The stock was sold at an average price of $14.66, for a total value of $131,940.00.
• On Tuesday, February 10th, Bayview Legacy, Llc sold 2,756 shares of Arteris stock. The shares were sold at an average price of $15.03, for a total value of $41,422.68.
• On Monday, February 9th, Bayview Legacy, Llc sold 47,244 shares of Arteris stock. The shares were sold at an average price of $15.21, for a total value of $718,581.24.
• On Thursday, January 15th, Bayview Legacy, Llc sold 17,884 shares of Arteris stock. The shares were sold at an average price of $17.84, for a total value of $319,050.56.
• On Tuesday, January 13th, Bayview Legacy, Llc sold 2,116 shares of Arteris stock. The stock was sold at an average price of $17.79, for a total value of $37,643.64.
• On Thursday, January 8th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $16.58, for a total value of $829,000.00.

Arteris Stock Performance

AIP traded down $0.47 during midday trading on Thursday, hitting $15.15. The stock had a trading volume of 11,380 shares, compared to its average volume of 480,620. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $19.85. The business has a fifty day moving average of $15.84 and a 200 day moving average of $14.01. The company has a market cap of $688.87 million, a P/E ratio of -18.36 and a beta of 1.45.

Arteris (NASDAQ:AIP) last posted its quarterly earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The business had revenue of $20.14 million for the quarter, compared to analysts’ expectations of $18.55 million. On average, equities research analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current year.

More Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Recent quarterly results showed Arteris beat expectations: EPS of ($0.05) vs. consensus ($0.08) and revenue of $20.14M vs. $18.55M, signaling better-than-expected near-term performance (this remains a positive fundamental datapoint for investors).
• Neutral Sentiment: The MSN piece titled “Why Arteris, Inc. (AIP) is in focus” highlights recent trading activity and investor attention; it may be amplifying interest but does not introduce new company-specific fundamentals. Article Link
• Neutral Sentiment: Reported short-interest data for early March appears to be anomalous/invalid (shows 0 shares and NaN changes). Given the questionable reporting, this item is unlikely to be a reliable driver of price action until corrected by an authoritative update.
• Negative Sentiment: Insider/major-holder selling: CEO K. Charles Janac and major shareholder Bayview Legacy, LLC executed sales on March 9–10 totaling 50,000 shares (41,000 @ $14.21 and 9,000 @ $14.66) for combined proceeds of ~$714,550. These filings and the size of the sales are prompting investor concern about insider liquidity and near-term share pressure. SEC filings: Janac Filing and Bayview Filing

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research note on Wednesday, January 21st. Rosenblatt Securities reaffirmed a “buy” rating and set a $20.00 price objective on shares of Arteris in a research note on Friday, February 13th. Finally, Northland Securities set a $24.00 target price on Arteris in a research note on Friday, February 13th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $20.17.

Institutional Investors Weigh In On Arteris

Institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC bought a new stake in Arteris in the 1st quarter worth $1,621,000. Strs Ohio bought a new position in shares of Arteris during the first quarter valued at about $104,000. Savant Capital LLC bought a new position in shares of Arteris during the second quarter valued at about $97,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Arteris during the second quarter worth about $151,000. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in shares of Arteris during the second quarter worth about $254,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.